Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis

Multiple Sclerosis Journal

Volumn 19, Issue 2, 2013, Pages 188-198

  Tutuncu, Melih ^a   Tang, Junger ^a   Zeid, Nuhad Abou ^b,d   Kale, Nilufer ^c,d   Crusan, Daniel J ^d   Atkinson, Elizabeth J ^d   Siva, Aksel ^e   Pittock, Sean J ^a   Pirko, Istvan ^a   Keegan, B Mark ^a   Lucchinetti, Claudia F ^a   Noseworthy, John H ^a   Rodriguez, Moses ^a   Weinshenker, Brian G ^a   Kantarci, Orhun H ^a  

^a MAYO CLINIC   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c Bakirkoy State Hospital   (Turkey)

^d Mayo Clinic   (United States)

^e ISTANBUL UNIVERSITY   (Turkey)

Author keywords

disability; EDSS; Multiple sclerosis; outcome measurement; progressive; relapsing remitting

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; OUTCOME ASSESSMENT; PATIENT REFERRAL; SEX RATIO;

EID: 84873694378     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512451510     Document Type: Article

References (38)

1. Kantarci OH, Weinshenker BG.. Natural history of multiple sclerosis. Neurologic Clinics. 2005 ; 23: 17-38
2. Confavreux C, Vukusic S.. Natural history of multiple sclerosis: a unifying concept. Brain. 2006 ; 129: 606-616
3. Lublin FD, Reingold SC.. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 ; 46: 907-911
4. Wolinsky JS.. The diagnosis of primary progressive multiple sclerosis. J Neurol Sci. 2003 ; 206: 145-152
5. Kremenchutzky M, Rice GP, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain. 2006 ; 129: 584-594
6. Tremlett H, Zhao Y, Devonshire V.. Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities. J Neurol. 2009 ; 256: 374-381
7. Koch M, Mostert J, Heersema D, et al. Progression in multiple sclerosis: further evidence of an age dependent process. J Neurol Sci. 2007 ; 255: 35-41
8. Scalfari A, Neuhaus A, Daumer M, et al. Age and disability accumulation in multiple sclerosis. Neurology. 77: 1246-1252
9. Kantarci O, Siva A, Eraksoy M, et al. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology. 1998 ; 51: 765-772
10. Kurtzke JF.. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 ; 33: 1444-1452
11. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
12. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005 ; 58: 840-846
13. Rodriguez M, Siva A, Ward J, et al. Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota. Neurology. 1994 ; 44: 28-33
14. Pittock SJ, Mayr WT, McClelland RL, et al. Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology. 2004 ; 62: 51-59
15. Kantarci OH, Hebrink DD, Achenbach SJ, et al. Association of APOE polymorphisms with disease severity in MS is limited to women.[see comment]. Neurology. 2004 ; 62: 811-814
16. McDonnell GV, Cabrera-Gomez J, Calne DB, et al. Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 years. Mult Scler. 2003 ; 9: 204-209
17. Siva A, Saip S, Altintas A, et al. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler. 2009 ; 15: 918-927
18. Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis. The radiologically isolated syndrome. Neurology. 2009 ; 72: 800-805
19. Lebrun C, Bensa C, Debouverie M, et al. Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry. 2008 ; 79: 195-198
20. Yeh EA, Chitnis T, Krupp L, et al. Pediatric multiple sclerosis. Nat Rev. 2009 ; 5: 621-631
21. Renoux C, Vukusic S, Mikaeloff Y, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med. 2007 ; 356: 2603-2613
22. Westlye LT, Walhovd KB, Dale AM, et al. Life-span changes of the human brain white matter: diffusion tensor imaging (DTI) and volumetry. Cereb Cortex. 20: 2055-2068
23. Hasan KM, Kamali A, Abid H, et al. Quantification of the spatiotemporal microstructural organization of the human brain association, projection and commissural pathways across the lifespan using diffusion tensor tractography. Brain Struct Funct. 214: 361-373
24. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 ; 69: 292-302
25. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol. 1991 ; 29: 53-62
26. Thompson AJ, Polman CH, Miller DH, et al. Primary progressive multiple sclerosis. Brain. 1997 ; 120: 1085-1096
27. Bramow S, Frischer JM, Lassmann H, et al. Demyelination versus remyelination in progressive multiple sclerosis. Brain. 2010 ; 133: 2983-2998
28. Kappos L, Weinshenker B, Pozzilli C, et al. Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials. Neurology. 2004 ; 63: 1779-1787
29. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 1989 ; 112: 133-146
30. Confavreux C, Aimard G, Devic M.. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain. 1980 ; 103: 281-300
31. Runmarker B, Andersen O.. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain. 1993 ; 116: 117-134
32. Confavreux C, Vukusic S.. Age at disability milestones in multiple sclerosis. Brain. 2006 ; 129: 595-605
33. Tremlett H, Yousefi M, Devonshire V, et al. Impact of multiple sclerosis relapses on progression diminishes with time. Neurology. 2009 ; 73: 1616-1623
34. Bennetto L, Burrow J, Sakai H, et al. The relationship between relapse, impairment and disability in multiple sclerosis. Mult Scler. 2011 ; 17: 1218-1224
35. Bejaoui K, Rolak LA.. What is the risk of permanent disability from a multiple sclerosis relapse?. Neurology. 2010 ; 74: 900-902
36. Gholipour T, Healy B, Baruch NF, et al. Demographic and clinical characteristics of malignant multiple sclerosis. Neurology. 2011 ; 76: 1996-2001
37. Trojano M, Liguori M, Bosco Zimatore G, et al. Age-related disability in multiple sclerosis. Ann Neurol. 2002 ; 51: 475-480
38. Confavreux C, Vukusic S.. Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment. Clin Neurol Neurosurg. 2006 ; 108: 327-332